SCHEMBL24239163

SCHEMBL24239163

c1ccc(-c2nc(-c3ccccc3-c3cccc4c3sc3c5ccccc5ccc43)nc(-c3cccc4oc5c(-c6ccc7ccccc7c6)cccc5c34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 4/20 0.35
▸ CYP1B1 Q16678 4/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HPGD P15428 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24239122 0.94 CYP1A1 (0.37) CYP1A1CYP1B1ALOX5PRKDCALDH1A1
SCHEMBL24239181 0.93 CYP1A1 (0.36) CYP1A1CYP1B1ALOX5PRKDCALDH1A1
SCHEMBL21425110 0.91 ALOX5 (0.39) ALOX5PRKDCALDH1A1KDM4EHSD17B10
SCHEMBL23819368 0.90 CYP1A1 (0.38) CYP1A1CYP1B1PRKDCALDH1A1MAPT
SCHEMBL23820595 0.89 CYP1A1 (0.37) CYP1A1CYP1B1ALOX5PRKDCALDH1A1
SCHEMBL24239142 0.88 CYP1A1 (0.38) CYP1A1CYP1B1ALDH1A1MAPTKDM4E
SCHEMBL23819540 0.87 ALOX5 (0.44) CYP1A1CYP1B1ALOX5PRKDCALDH1A1
SCHEMBL23821458 0.87 CYP1A1 (0.35) CYP1A1CYP1B1ALOX5ALDH1A1MAPT
SCHEMBL23820396 0.87 ALOX5 (0.41) ALOX5PRKDCALDH1A1KDM4EHSD17B10
SCHEMBL23820144 0.86 ALOX5 (0.43) CYP1A1CYP1B1ALOX5PRKDCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-24 — — US disclosed
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-13 — — US disclosed
US-20220037594-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115134-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 CYP1A1 897/4885CYP1B1 2461/4885ALOX5 624/4885
US-11800795-B2 Compound for organic electric element, organic electric element using the same, and an electronic device thereof PIEZO1, ORAI2, OCIAD1 CYP1A1 787/4885CYP1B1 1728/4885ALOX5 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback